NIH Grants $470 Million for Study of Long COVID

The study aims to recruit 40,000 adults and children to get a better sense of the condition that can last weeks or months after infection.

| 2 min read
Man sitting on bed with his head in his hands

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ABOVE: © ISTOCK.COM, TZIDO

After becoming infected with SARS-CoV-2, the majority of people recover in a couple of weeks. For a significant number of patients, though, symptoms can hang on for more than four months, a condition known as long COVID. The National Institutes of Health (NIH) announced yesterday (September 15) that it has awarded a $470 million grant to the REsearching COVID to Enhance Recovery (RECOVER) Initiative to study 40,000 people for more insights into the mechanisms behind the condition, along with possible treatments.

In June, the NIH announced the creation of the RECOVER Initiative to study how and why some people with past SARS-CoV-2 infections experience symptoms such as fatigue, loss of taste and/or smell, coughing, and mental fog for months on end. RECOVER now boasts more than 100 researchers from more than 30 institutions, and close to half a billion dollars in funding.

“We know some people ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Lisa Winter

    Lisa Winter became social media editor for The Scientist in 2017. In addition to her duties on social media platforms, she also pens obituaries for the website. She graduated from Arizona State University, where she studied genetics, cell, and developmental biology.
Share
A greyscale image of cells dividing.
March 2025, Issue 1

How Do Embryos Know How Fast to Develop

In mammals, intracellular clocks begin to tick within days of fertilization.

View this Issue
Discover the history, mechanics, and potential of PCR.

Become a PCR Pro

Integra Logo
Explore polypharmacology’s beneficial role in target-based drug discovery

Embracing Polypharmacology for Multipurpose Drug Targeting

Fortis Life Sciences
3D rendered cross section of influenza viruses, showing surface proteins on the outside and single stranded RNA inside the virus

Genetic Insights Break Infectious Pathogen Barriers

Thermo Fisher Logo
A photo of sample storage boxes in an ultra-low temperature freezer.

Navigating Cold Storage Solutions

PHCbi logo 

Products

The Scientist Placeholder Image

Gilead’s Capsid Revolution Meets Our Capsid Solutions: Sino Biological – Engineering the Tools to Outsmart HIV

Stirling Ultracold

Meet the Upright ULT Built for Faster Recovery - Stirling VAULT100™

Stirling Ultracold logo
Chemidoc

ChemiDoc Go Imaging System ​

Bio-Rad
The Scientist Placeholder Image

Evotec Announces Key Progress in Neuroscience Collaboration with Bristol Myers Squibb